212 related articles for article (PubMed ID: 24718373)
21. Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine Dependence.
Okita K; Mandelkern MA; London ED
Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27634830
[TBL] [Abstract][Full Text] [Related]
22. Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies.
Ashok AH; Mizuno Y; Howes OD
Psychopharmacology (Berl); 2019 Apr; 236(4):1119-1129. PubMed ID: 30887059
[TBL] [Abstract][Full Text] [Related]
23. Salience attribution and its relationship to cannabis-induced psychotic symptoms.
Bloomfield MA; Mouchlianitis E; Morgan CJ; Freeman TP; Curran HV; Roiser JP; Howes OD
Psychol Med; 2016 Dec; 46(16):3383-3395. PubMed ID: 27628967
[TBL] [Abstract][Full Text] [Related]
24. Positron emission tomographic measure of brain dopamine dependence to nicotine as a model of drugs of abuse.
Domino EF; Tsukada H; Harada N
Psychopharmacology (Berl); 2009 May; 204(1):149-53. PubMed ID: 19137279
[TBL] [Abstract][Full Text] [Related]
25. Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers.
Di Ciano P; Tyndale RF; Mansouri E; Hendershot CS; Wilson AA; Lagzdins D; Houle S; Boileau I; Le Foll B
Int J Neuropsychopharmacol; 2018 Jun; 21(6):503-512. PubMed ID: 29346545
[TBL] [Abstract][Full Text] [Related]
26. Systemic inflammation enhances stimulant-induced striatal dopamine elevation in tobacco smokers.
Zakiniaeiz Y; Hoye J; Ryan Petrulli J; LeVasseur B; Stanley G; Gao H; Najafzadeh S; Ropchan J; Nabulsi N; Huang Y; Chen MK; Matuskey D; Barron DS; Kelmendi B; Fulbright RK; Hampson M; Cosgrove KP; Morris ED
Brain Behav Immun; 2022 Nov; 106():262-269. PubMed ID: 36058419
[TBL] [Abstract][Full Text] [Related]
27. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors.
Brody AL; Mandelkern MA; London ED; Olmstead RE; Farahi J; Scheibal D; Jou J; Allen V; Tiongson E; Chefer SI; Koren AO; Mukhin AG
Arch Gen Psychiatry; 2006 Aug; 63(8):907-15. PubMed ID: 16894067
[TBL] [Abstract][Full Text] [Related]
28. Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.
Petty A; Garcia-Hidalgo A; Halff EF; Natesan S; Withers DJ; Irvine EE; Kokkinou M; Wells LA; Bonsall DR; Tang SP; Veronese M; Howes OD
Mol Imaging Biol; 2023 Dec; 25(6):1054-1062. PubMed ID: 37872462
[TBL] [Abstract][Full Text] [Related]
29. Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Howes OD; Montgomery AJ; Asselin MC; Murray RM; Valli I; Tabraham P; Bramon-Bosch E; Valmaggia L; Johns L; Broome M; McGuire PK; Grasby PM
Arch Gen Psychiatry; 2009 Jan; 66(1):13-20. PubMed ID: 19124684
[TBL] [Abstract][Full Text] [Related]
30. The influence of conditioned stimuli on [
Di Ciano P; de Wit H; Mansouri E; Houle S; Boileau I; Le Foll B
Sci Rep; 2021 Jun; 11(1):11667. PubMed ID: 34083612
[TBL] [Abstract][Full Text] [Related]
31. Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse.
Fehr C; Yakushev I; Hohmann N; Buchholz HG; Landvogt C; Deckers H; Eberhardt A; Kläger M; Smolka MN; Scheurich A; Dielentheis T; Schmidt LG; Rösch F; Bartenstein P; Gründer G; Schreckenberger M
Am J Psychiatry; 2008 Apr; 165(4):507-14. PubMed ID: 18316420
[TBL] [Abstract][Full Text] [Related]
32. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
33. PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium.
Yatham LN; Liddle PF; Shiah IS; Lam RW; Ngan E; Scarrow G; Imperial M; Stoessl J; Sossi V; Ruth TJ
Am J Psychiatry; 2002 May; 159(5):768-74. PubMed ID: 11986130
[TBL] [Abstract][Full Text] [Related]
34. The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: an [18F]-DOPA PET study.
Dahoun T; Pardiñas AF; Veronese M; Bloomfield MAP; Jauhar S; Bonoldi I; Froudist-Walsh S; Nosarti C; Korth C; Hennah W; Walters J; Prata D; Howes OD
Hum Mol Genet; 2018 Oct; 27(20):3498-3506. PubMed ID: 29945223
[TBL] [Abstract][Full Text] [Related]
35. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.
Howes OD; Bose SK; Turkheimer F; Valli I; Egerton A; Valmaggia LR; Murray RM; McGuire P
Am J Psychiatry; 2011 Dec; 168(12):1311-7. PubMed ID: 21768612
[TBL] [Abstract][Full Text] [Related]
36. Denicotinized versus average nicotine tobacco cigarette smoking differentially releases striatal dopamine.
Domino EF; Ni L; Domino JS; Yang W; Evans C; Guthrie S; Wang H; Koeppe RA; Zubieta JK
Nicotine Tob Res; 2013 Jan; 15(1):11-21. PubMed ID: 22491891
[TBL] [Abstract][Full Text] [Related]
37. Increased Striatal Dopamine Synthesis Capacity in Gambling Addiction.
van Holst RJ; Sescousse G; Janssen LK; Janssen M; Berry AS; Jagust WJ; Cools R
Biol Psychiatry; 2018 Jun; 83(12):1036-1043. PubMed ID: 28728675
[TBL] [Abstract][Full Text] [Related]
38. Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette.
Brody AL; Mandelkern MA; Olmstead RE; Allen-Martinez Z; Scheibal D; Abrams AL; Costello MR; Farahi J; Saxena S; Monterosso J; London ED
Neuropsychopharmacology; 2009 Jan; 34(2):282-9. PubMed ID: 18563061
[TBL] [Abstract][Full Text] [Related]
39. Determinants of treatment response in first-episode psychosis: an
Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Turkheimer FE; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
Mol Psychiatry; 2019 Oct; 24(10):1502-1512. PubMed ID: 29679071
[TBL] [Abstract][Full Text] [Related]
40. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers.
McKinney EF; Walton RT; Yudkin P; Fuller A; Haldar NA; Mant D; Murphy M; Welsh KI; Marshall SE
Pharmacogenetics; 2000 Aug; 10(6):483-91. PubMed ID: 10975602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
